Literature DB >> 25582577

Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.

Djordje P Medarević1, Kyriakos Kachrimanis2, Miodrag Mitrić3, Jelena Djuriš1, Zorica Djurić1, Svetlana Ibrić1.   

Abstract

This study investigates the potential of poloxamers as solid dispersions (SDs) carriers in improving the dissolution rate of a poorly soluble drug, carbamazepine (CBZ). Solid dispersions were prepared with poloxamer 188 (P188) and poloxamer 407 (P407) by melting method in different drug:carrier ratios (1:1, 1:2 and 1:3). Prepared samples were characterized using differential scanning calorimetry (DSC), hot-stage polarized light microscopy (HSM), powder X-ray diffraction (PXRD) and Fourier transform infrared spectroscopy (FT-IR) to investigate drug physical state within the SDs matrix, possible polymorphic transitions and drug-polymer interactions. The interactions between CBZ molecules and polymeric chains were also evaluated using molecular dynamics simulation (MDS) technique. The most thermodynamically stable polymorphic form III of CBZ was present in all SDs, regardless of the type of poloxamer and drug-to-carrier ratio. The absence of drug-polymer interactions was observed by FT-IR analysis and additionally confirmed by MDS. Formation of persistent hydrogen bond between two CBZ molecules, observed by MDS indicate high tendency of CBZ molecules to aggregate and form crystalline phase within dispersion. P188 exhibit higher efficiency in increasing CBZ dissolution rate due to its more pronounced hydrophilic properties, while increasing poloxamers concentration resulted in decreasing drug release rate, as a consequence of their thermoreversible gelation.

Entities:  

Keywords:  Carbamazepine; dissolution rate; molecular dynamics; physicochemical characterization; poloxamers; solid dispersions

Mesh:

Substances:

Year:  2015        PMID: 25582577     DOI: 10.3109/10837450.2014.996899

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  8 in total

1.  Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion.

Authors:  Suhas G Gumaste; Simerdeep Singh Gupta; Abu T M Serajuddin
Journal:  AAPS J       Date:  2016-06-14       Impact factor: 4.009

2.  Novel olive oil phenolic (-)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities.

Authors:  Mohammed H Qusa; Abu Bakar Siddique; Sami Nazzal; Khalid A El Sayed
Journal:  Int J Pharm       Date:  2019-08-05       Impact factor: 5.875

Review 3.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

4.  Investigating the molecular dissolution process of binary solid dispersions by molecular dynamics simulations.

Authors:  TengIan Chan; Defang Ouyang
Journal:  Asian J Pharm Sci       Date:  2017-10-23       Impact factor: 6.598

Review 5.  Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.

Authors:  Serena Bertoni; Beatrice Albertini; Nadia Passerini
Journal:  Molecules       Date:  2019-09-25       Impact factor: 4.411

6.  The guest polymer effect on the dissolution of drug-polymer crystalline inclusion complexes.

Authors:  Lu Chen; Yanbin Huang
Journal:  RSC Adv       Date:  2021-04-07       Impact factor: 3.361

7.  The Effect of Surfactant Type and Concentration on Physicochemical Properties of Carvedilol Solid Dispersions Prepared by Wet Milling Method.

Authors:  Noushin Bolourchian; Mina Shafiee Panah
Journal:  Iran J Pharm Res       Date:  2022-05-09       Impact factor: 1.962

8.  Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine.

Authors:  Tanja Vojinović; Djordje Medarević; Edina Vranić; Zorica Potpara; Marko Krstić; Jelena Djuriš; Svetlana Ibrić
Journal:  Saudi Pharm J       Date:  2018-02-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.